In contrast, Kras activation in combination with heterozygous PTEN deletion induced mixed carcinomas of liver (both iCCA and HCC), whereas Kras activation alone did not induce biliary tract neoplasm [188]. Here, KRAS is linked to hepatocellular carcinoma.